​Steven Levy

​Steven is a Partner at Unorthodox Ventures where he focuses on investing in venture stage MedTech companies. Before joining Unorthodox Ventures, Steven worked for the prior 23 years as an investment banker, having held senior roles at Lehman Brothers, Stifel Financial and Cowen & Co. Steven has executed over 100 transactions with aggregate deal value in excess of $30 billion. Steven headed the M&A efforts for the Financial Sponsors practice at Lehman Brothers, covered Financial sponsors and headed the Consumer M&A efforts at Cowen and covered Financial Sponsors, led execution on technology and consumer M&A transactions and headed up the firm’s investment banking efforts in Israel at Stifel.

​Steven received his B.A. from Binghamton University and graduated as a member of Phi Beta Kappa and received his M.B.A. from the Wharton School, at the University of Pennsylvania.

Bryan Spielman is a Managing Partner at Northwell Health Equity Partners. He is a seasoned C-suite executive with a track record of driving multi-billion-dollar value creation across the healthcare and technology sectors. Most recently, as Chief Growth Officer at Advarra, he spearheaded the company’s $5 billion sale to Blackstone and CPPIB. Prior to that, at Medidata, he helped scale the company from a $400 million to over $2.3 billion market valuation. Bryan spent 12 years in investment banking at Centerview Partners, UBS, and Bear Stearns, advising on over $50 billion in transactions. He holds an MBA from NYU Stern School of Business and a BA from the University of Pennsylvania.

Host/Moderator:

Maria Putilina, MD, MS, is a medical advisor and innovator, boasting over a decade of driving transformative change within the healthcare industry. Her expertise spans Business Administration, Medicine, and Science, which she honed in healthcare consulting, helping companies build and execute innovation strategies.

Marissa Fayer has spent 25+ years operating at the intersection of technology and women’s health. She’s CEO of DeepLook Medical, an FDA-cleared AI diagnostics company focused on improving cancer detection for patients with dense breast tissue, and CEO/founder of HERhealthEQ, a nonprofit that’s improved the health outcomes of 151,000+ women in 13 different countries by expanding access to medical devices and equipment. Marissa approaches women’s health as infrastructure: when properly funded and built, it drives measurable returns across economies, workforces, and communities. Previously, Marissa held executive roles at Hologic, Olympus, Maquet Getinge, and has consulted for organizations including Pfizer, the National Institutes of Health (NIH), NuVasive, and Boehringer Ingelheim. She currently serves as an Investment Committee Member of GG Ventures, a 2026-2028 World Economic Forum (WEF) Technology Fellow, is an active founding member of Milken Institute’s Women’s Health Committee, and advisor to Welwaze Medical, Impact.51, and TechThrive Ventures. Marissa is the author of Undervalued to Unavoidable: Women’s Health as Infrastructure. Marissa is a TEDx speaker (2019 TEDxLugano), has delivered keynotes at leading global healthcare conferences, and has been recognized as a Top 100 Women in Medtech and a Medtech Voice to Follow. Marissa can be found at www.marissafayer.com

Lyne Landry is a venture capital investor, corporate director, and M&A executive with more than 20 years of experience deploying private capital across North America, Europe, and Africa. She is the Founding & Managing Partner of AgeTech Capital, a fund focused on high-growth opportunities driven by an aging population across health, wealth, and care.

An ICD.D-certified director, Lyne has backed 14 companies, delivered a successful exit, and invested in a unicorn. She is also the co-founder of the AgeTech Investor Network (created with AARP’s AgeTech Collaborative) and sits on the board of the National Research Council of Canada’s Aging in Place program.

Lyne helps portfolio companies scale by providing strategic governance, deep market insights, and access to an extensive global network in the longevity economy.

Nicolas Saint-Arnaud is a partner at iA Seed Ventures, startup founder, investor, and hands-on operator with extensive expertise in health tech, fintech, and AI. As an engineer and product leader, he specializes in guiding early-stage founders, scaling technology organizations, and taking products from early validation to strong market fit and major revenue growth.

With a deep technical acumen and a track record of building and leading complex tech teams, Nicolas combines strategic vision with execution. He actively mentors founders and advises early-stage startups on product strategy, team building, and scaling predictable go-to-market operations.